Search results
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 2 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients ...
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 6 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis...
Medical Xpress· 3 days agoThe findings lay the groundwork to identify therapeutic targets in non-clear-cell renal cell carcinomas. ...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 4 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Bavencio Side Effects: What They Are and How to Manage Them
Healthline· 3 days agoBavencio (avelumab) is a prescription drug used to treat certain types of kidney, bladder, and skin cancer. Bavencio can cause side effects that range from mild to serious. Examples include ...
YOUR HEALTH: Why some kidney cancer patients are living longer
WAFB Baton Rouge· 2 days agoKidney cancer is among the 10 most common cancers in both men and women. A decade ago, advanced...
Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy - Nature...
Nature· 2 days agoDual blockade therapy is currently being trialled for multiple tumour types, but efficacy is variable. Here, the authors use longitudinal proteomics profiling of 22 patients to develop a predictive model of therapy response.
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoIn Q1 2024, no additional molecules advanced into the clinic, and we maintained the cumulative total...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 4 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...